Tylenol use in pregnancy fell after Trump's autism warning: study
Source: SeekingAlpha
2026-03-06 14:58:14 ET
More on Kenvue, GSK
- Kenvue: Out Of Favor Then, Under Pressure Now
- GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)
- Kimberly-Clark: After The Kenvue Merger Vote, Ready To Rumble?
- CDC acting director calls for measles vaccination
- Kenvue effort to dismiss Tylenol case rejected by Texas judge
Read the full article on Seeking Alpha
For further details see:
Tylenol use in pregnancy fell after Trump’s autism warning: study
Kenvue Inc.
NASDAQ: KVUE
KVUE Trading
-0.44% G/L:
$18.11 Last:
9,285,238 Volume:
$18.19 Open:
KVUE Latest News
March 04, 2026 03:24:44 pm
Starboard Value Takes Stake in Fluor as Industrial Investment Cycles Reaccelerate
February 27, 2026 10:46:07 pm
Starboard Value LP Opens Major Stake in Clearwater Analytics' Investment Accounting Platform
February 18, 2026 05:29:29 pm
Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations
KVUE Stock Data
$35,097,495,754
1,883,616,694
N/A
492
N/A
Consumer Products - Healthcare
Consumer Staples
US
Summit
